Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 130,126 | 77,428 | 23,638 | 3,154 | 0 |
| Cost of Goods | 13,368 | 9,302 | 2,133 | 599 | N/A |
| Gross Profit | 116,758 | 68,126 | 21,505 | 2,555 | N/A |
| Operating Expenses | 382,629 | 252,785 | 200,795 | 173,213 | 136,575 |
| Operating Income | -265,503 | -184,357 | -179,157 | -170,059 | -136,575 |
| Interest Expense | 20,603 | 13,892 | 5,201 | 0 | 0 |
| Other Income | 25,850 | 14,135 | 3,239 | 100,447 | 2,579 |
| Pre-tax Income | -260,256 | -184,114 | -181,119 | -69,612 | -133,996 |
| Income Tax | 346 | 564 | N/A | N/A | N/A |
| Net Income Continuous | -260,602 | -184,678 | -181,119 | -69,612 | -133,996 |
| Net Income | $-260,602 | $-184,678 | $-181,119 | $-69,612 | $-133,996 |
| EPS Basic Total Ops | -4.34 | -3.20 | -3.47 | -1.40 | -3.04 |
| EPS Basic Continuous Ops | -4.27 | -3.20 | -3.48 | -1.40 | -3.04 |
| EPS Diluted Total Ops | -4.34 | -3.20 | -3.47 | -1.40 | -3.04 |
| EPS Diluted Continuous Ops | -4.27 | -3.20 | -3.48 | -1.40 | -3.04 |
| EPS Diluted Before Non-Recurring Items | -4.34 | -3.20 | -3.47 | -1.40 | -3.04 |
| EBITDA(a) | $-263,940 | $-182,599 | $-177,485 | $-168,901 | $-135,885 |